3D printed implants for treatment of bone defects

BellaSeno GmbH announced a collaboration with Charite – Universitaetsmedizin Berlin under the recently established SyMBoD consortium. Under the agreement, BellaSeno will design and manufacture personalized, 3D-printed, absorbable implants suitable for the treatment of diabetes patients with bone defects.

Photo

The goal is to restore blood supply and facilitate the regeneration of persistent bone defects that do not heal otherwise. The consortium is an interdisciplinary project covering innovative digital technology based on systems medicine and precise, reproducible additive manufacturing. Within the consortium, BellaSeno is fully responsible for ISO 13485-compliant, medical-grade scaffold manufacturing. 

“Current research suggests that 3D printed scaffolds, which have been optimized mechanically and biologically, can improve bone regeneration,” said Dr. Navid Khani, Head of R&D of BellaSeno. “Our custom-made, high-speed additive manufacturing platform is very precise, generates highly reproducible structures and has been certified according to ISO 13485 standard. We are therefore very well positioned to produce state-of-the-art, medical-grade scaffolds for a variety of applications. This is the first project underlining our manufacturing capabilities for external industry and academic partners.”

“We have selected BellaSeno because of the team´s unique expertise in additive manufacturing of porous structures with extremely small features as required for our intended application,” said Dr. Su Ping Patrina Poh of Charite’s Julius Wolff Institute (JWI). “This strategic inclusion of BellaSeno is also driven by the fact that, to our knowledge, they are the only company within Germany with the capability to perform the entire additive design and manufacturing process chain with ISO13485 certified processes, which is highly aligned with our intention of clinical translation in the future.”

BellaSeno is producing 3D printed absorbable implants in very high-resolution lattice-based structures using melt-extrusion technology. While numerous companies can manufacture porous structures using 3 -printing technologies, it is extremely challenging to reproducibly generate structures if the required unit-cell size is less than 3 mm. Using its custom-built Yasham additive manufacturing platform, BellaSeno can reproducibly and routinely manufacture scaffolds with unit cell sizes down to about 1 mm.

SyMBoD consortium

The SyMBoD consortium consists of 4 universities and 1 industry partner and is dedicated to developing novel, personalized treatments for endogenous bone regeneration in patients with diabetes. Funded by Germany's Ministry for Education and Research (BMBF) and led by Charité Universitätsmedizin Berlin, the project includes partner institutions such as University of Freiburg, Fraunhofer IZI, Technical University of Munich, and Genvention GmbH. SyMBoD is part of BMBF's e:Med initiative, which is supporting various system medicine consortia with a total budget of EUR 200 million over the course of eight years.

Subscribe to our newsletter

Related articles

3D printing patient-specific implants

3D printing patient-specific implants

Researchers have developed a personalized therapeutic concept that significantly reduces the chances of a patient suffering post-operative complications.

The role of surgical 3D printing in hospitals

The role of surgical 3D printing in hospitals

More and more hospitals are entering the world of 3D printing in surgery as decision-makers and surgeons are realising the immense benefits for surgeons and patients alike.

3D printed rubbery brain implants

3D printed rubbery brain implants

Engineers are working on developing soft, flexible neural implants that can gently conform to the brain’s contours and monitor activity over longer periods.

Diabetes: 3D printed sensors for breath tests

Diabetes: 3D printed sensors for breath tests

Researchers have developed a procedure to produce extremely sensitive and energy-efficient sensors using 3D printing.

An universal carrier ink for 3D printing

An universal carrier ink for 3D printing

Researchers have produced a gel from cellulose fibres and biodegradable nanoparticles that liquifies when pressed through the nozzle of a 3D printer, but then quickly returns to its original shape.

Therapies without drugs

Therapies without drugs

Researchers are investigating the potential of microimplants to stimulate nerve cells and treat chronic conditions like asthma, diabetes, or Parkinson’s disease.

3D printed implants seed multiple layers of tissue

3D printed implants seed multiple layers of tissue

Researchers are 3D printing "groovy" tissue-engineering scaffolds with living cells to help heal injuries.

Step foward for 3D printing a bioprosthetic ovary

Step foward for 3D printing a bioprosthetic ovary

Ongoing development of an "ink" will be used for 3D printing an artificial (or bio-prosthetic) ovary that could be implanted and allow a woman to have a child.

Groundwork for patient-specific 3D printed meniscus

Groundwork for patient-specific 3D printed meniscus

Researchers have developed a novel methodology to provide non-invasive analysis of meniscal implants.

Popular articles